Navigation Links
Ebola Virus Thwarted After Exposure

Successful treatment in monkeys offers hope for humans, researchers say

FRIDAY, May 28 (HealthDay News) -- Researchers report that they've disrupted the ability of the Ebola virus to replicate in monkeys, potentially suggesting a treatment for humans who get infected with the lethal disease.

The study is the first to show that the treatment helps monkeys after exposure to the Ebola virus. Previous research showed that it worked when given as a vaccine before exposure.

The study, reported by Thomas W. Geisbert of Boston University School of Medicine and colleagues, focuses on bits of genetic material that target a protein that the virus needs to reproduce.

The notoriously deadly Ebola virus, found in Africa, causes massive bleeding and kills as many as 90 percent of the people it infects. Earlier this month, researchers reported that they'd created a vaccine that protects monkeys against three strains of the virus.

The findings were published May 27 in The Lancet.

More information

For more on research on Ebola fever and other acute viral diseases, see the National Institute of Allergy and Infectious Diseases.

-- Randy Dotinga

SOURCE: The Lancet, press release, May 27, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Experimental Vaccine Shields Monkeys Against Ebola
2. Scripps Research scientists reveal key structure from ebola virus
3. Anti-HIV Drugs May Help Prevent Spread of Virus
4. To attack H1N1, other flu viruses, gold nanorods deliver potent payload
5. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
6. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
7. Doctors Can Use Rotavirus Vaccine Again: FDA
8. Rotavirus Vaccine Helps Kids Avoid Severe Gastro Illness
9. Study finds rotavirus vaccine greatly reduces hospitalizations for acute gastroenteritis in children
10. Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
11. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from reveals that behind the ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: